This inventor holds 1 USPTO granted patent. Top assignees: Gentier Biosystems, Inc., Nihon University. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 110 
Years Active: 2010
Title: Hirofumi Kishioka: Innovator in Gene Expression Inhibition
Introduction
Hirofumi Kishioka is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of gene expression inhibition, particularly through his innovative patent. His work has implications for understanding and potentially treating various health conditions.
Latest Patents
Hirofumi Kishioka holds a patent for a TGF-β gene expression inhibitor. This invention involves a pyrrole-imidazole polyamide that includes N-methylimidazole and γ-aminobutyrate units. The inhibitor is designed to target a specific region in the human transforming growth factor β1 (hTGF-β1) promoter, which is crucial for gene regulation.
Career Highlights
Throughout his career, Kishioka has worked with esteemed institutions such as Nihon University and Gentier Biosystems, Inc. His experience in these organizations has allowed him to develop his expertise in gene expression and molecular biology.
Collaborations
Kishioka has collaborated with notable colleagues, including Noboru Fukuda and Hiroshi Sugiyama. These partnerships have contributed to the advancement of research in his field.
Conclusion
Hirofumi Kishioka's innovative work in gene expression inhibition showcases his dedication to scientific advancement. His contributions are valuable to the ongoing research in molecular biology and genetics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile